Keep your patients breathing — and out of the ED
COPD exacerbations and asthma-related ED visits are among the most preventable high-cost utilization events in healthcare. The difference between a well-managed respiratory patient and an uncontrolled one is often medication adherence, timely spirometry, and proactive management — all of which require population-level tracking that your EHR does not provide.
Glance tracks inhaler and controller medication adherence, spirometry trending, exacerbation frequency, and pulmonary-specific HCC codes across your entire panel.
Schedule a Demo See FeaturesPulmonology-specific analytics
Respiratory disease management depends on adherence tracking, functional status monitoring, and early intervention before exacerbations become admissions.
Inhaler & Controller Adherence
Track PDC for inhaled corticosteroids, LABAs, LAMAs, and combination inhalers. Identify patients who are over-using rescue inhalers (a marker of poor control) relative to controller medications. Surface patients who have not refilled their controller in over 30 days.
Spirometry & PFT Trending
Track FEV1, FVC, and FEV1/FVC ratio over time for every patient. Reference ranges adjusted for age, sex, height, and ethnicity. Identify patients overdue for spirometry, those with declining trajectories, and those whose classification may need updating (e.g., GOLD stage progression).
Exacerbation & Utilization Tracking
Track ED visits and hospitalizations for COPD exacerbation, asthma exacerbation, pneumonia, and respiratory failure across your panel. Identify frequent exacerbators (2+ events per year) who need intensified management. Quantify the cost of each avoidable admission.
Pulmonary HCC Coding
Capture COPD severity (HCC 111), chronic respiratory failure (HCC 83), oxygen dependence, and interstitial lung disease. Surface suspected conditions from PFT results, oxygen orders, and hospitalization claims that are not reflected on the active problem list.
Respiratory Financial Analytics
COPD patients generate high inpatient costs that are largely preventable with proper outpatient management. Track PMPM costs for your respiratory population, model the ROI of pulmonary rehabilitation and medication adherence programs, and benchmark against VBC contract targets.
